PROJECT TEAM

Management team: Dr Einar Pontén

Dr. Maria Wanderoy, Director Drug Development
Doctoral degree in Neurochemistry and Neurotoxicology at Stockholm University. More than 25 years experiences from the pharmaceutical industry, e.g., AstraZeneca. Dr. Wanderoy has held positions ranging from global-, clinical- and preclinical project manager to senior research scientist and with that experience a broad understanding of the drug development process. She has also several years of experience as project manager for medical device development projects, for example, autoinjectors used for drug delivery in patients.
LinkedIn profile »

Management team: Dr Einar Pontén

Dr. Anneli Hällgren, Toxicology and Safety Program
Doctoral degree in physiology at Uppsala University. More than 20 years of experience from non-clinical research and development projects in different indications and product types. Dr. Hällgren had management and other leading positions related to preclinical development and pharmacology in companies such as KaroBio and Melacure Therapeutics.
LinkedIn profile »

Management team: Dr Einar Pontén

Dr. Mats Reslow, CMC
Doctoral degree in biotechnology at Lund University. More than 25 years of experience in research and development in biopharmacology and drug production. Dr. Reslow has worked as research manager at Bioglan Therapeutics AB, Skyepharma and between 2004 and 2016 as Principal Scientist at NovoNordisk A / S.
LinkedIn profile »

Management team: Dr Einar Pontén

Dr. Agneta Wennerholm, Clinical Studies
Doctoral degree in clinical pharmacology at Karolinska Institutet. Dr. Wennerholm has more than 20 years of experience in pharmaceutical and biotechnology companies, academic research and clinical CRO.
LinkedIn profile »

ABOUT US